{"name":"Opthea Limited","slug":"opthea-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNal9yb0poS19QYmQ1U3N3bGFzYXJ3VVFoNFZ1bFBEbWFTRGIwbmZOcVdqR0JaSWtsNjR1dVhjNzRaVFJLUzJBSDQtRUpha1VkNW9WSDdlY3pOd2FHeTRHXzhtUEZwMlJYSWFoWUhucWQ1eWdtTEkxNzR1MHlrSGpvUnBkZVE0ODlWQVpoRWhBS19iSUlXY3FsemVFd0xzV2RmOV91MUxSZ2NoWTFnNjFqQXF1QW83YzRTNDZlZ0FNYmZha1dGRjVNbzViMldQSXdyRXl6V1EtVmdRYlZOZHZuTnVQU2ZZR1NZQ0hqRmpuZkw1X09uRHMzd0duNlpOZlhULWMzRnVlajBBb3g0OWJYQnExeGNMc2ZqZHFuMld5YmFObkVMZFF0VXJLT3BpRVRFM3ZUS2Q4TGw4TDhLUUhGS1V4VU1kbS00Q0NR?oc=5","date":"2025-12-01","type":"pipeline","source":"globenewswire.com","summary":"Geographic Atrophy Market to Surge Significantly During the - globenewswire.com","headline":"Geographic Atrophy Market to Surge Significantly During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQdjA4NjRPMVVoaVhDdmI1M2tpb0pyWlNpd3hTLVRNT01zNXVJc3NPQUpnUUEyV1pqZWNUN2lXdFdDX3dkcUNuTklNWU9NMzNQWGFXcGtRNF94QW5BTkhnYTBqN25OTmpBUVB4YXZTalg5UnN3TkNKZTdqa0ZyM2Njc21EX1MtQ0F6Y19pVHlNeXM0R21OV3dKaU01aHNOSzRBcV9CWWlmNFlHS25hQ3R5S1VKRjQyRmZWOWE2UHNRclJEakY4X1ZLekEtNmViMkFpclRzaldDT1RVaHBoanhNbUJBVG41NUxtTE1XUGxfa3JaZXQwUW54enQ1cFN3NmtwUTJHUlR0c0tHWHRLTDFKSlNuSnlEaUNRa2JqYXk5aGZKQTdOaTk0YTVyUnpKaHRiNDQwNmJkUFFJS2dhckhpN3BxNVkzRjg?oc=5","date":"2025-11-17","type":"pipeline","source":"globenewswire.com","summary":"Dry Age-related Macular Degeneration Market Poised for - globenewswire.com","headline":"Dry Age-related Macular Degeneration Market Poised for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZE9PRmVQWVRQRVpGcC1idHlTMDktUmV2WWFzUTJFSkFNWnhmQWRFR3FNMDJOVUxrUG9mYTJRMUpZVmFkdlZyV3VRalhKTW5EeG9Wd0ExazhsakdCSkYtc0pLTzlkb0VMeE9uRzJWbnJVZ3VlMTB4R0owM2hveXFKMzJnTkhxVlZBY0gyWU8tanMwWDl0UTlRc1QtTHRvOXlVWHBLbXBidzZrXzBfaDZtWGtVcm90cmtZalFTdnpkWW5uNzAya3IyTg?oc=5","date":"2025-09-26","type":"pipeline","source":"Eyes On Eyecare","summary":"Leadership watch: SpyGlass, Lumata Health, and Horizon Surgical report changes - Eyes On Eyecare","headline":"Leadership watch: SpyGlass, Lumata Health, and Horizon Surgical report changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQaFVld3luVy0zdmZsbFBQcGd3MTZiV3JObzhEbHdjWFNqd0dGa2RqMVBfSG5VeHNhWVRTVmJzSEJ3RnBzdjA0cklTcjduWUV4ZHlLR2dXUXl2eURsTGpJbFVwcDl1R1hyTjN3U2tzQndQZHlIQjhYWGVwaFFYTUg1aW1OanoxLUNpeW44Tk9pdW04aU1qUDQ2LVNXZEROQWktd19xdjVCdnlyTXJBUVBwbS0tRGxkLXhXbEVvRmNHM0NNdGI5UVplZGkzNjk2LWJLT29TUGtnWUhmZnlqX09udWg2X1lCSUo3eWJhakx4cFRrWVA4STdtUGhSZ1Z0OE1iSlhfTi1LZzhXWkNNM1IxYWhSWFRGN3Vmc3lzY2ZudnJkY1h6?oc=5","date":"2025-05-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Denali Therapeutics (DNLI) and Agilon Health (AGL) - The Globe and Mail","headline":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Denali Therapeutics (DNLI) and Agilon Health (AGL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE8td3JiaUJtek9qeUhKemhIemtOVW01OXdqUUppM0Jrdi16NEpxSGtrNlJfYTVYRjhxa2p4U3lzU3VCTm1OM3BWejVKWHBpdkNzVnRN?oc=5","date":"2025-03-31","type":"trial","source":"FirstWord Pharma","summary":"Second study failure further clouds optics for Opthea - FirstWord Pharma","headline":"Second study failure further clouds optics for Opthea","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQSzZnWXBNRjNGOTFLX0JBeG5ORk1LYnJtQmVnUnRjQTFEVTJ2RjlHbUIxVUxaMERXU2dENDE1NFI0TTJDeTFKOWxRTG1XMTVxM3NjRWgxUjd5V0xYOGFpeUx2ekFsYWJ5UGZ0SDFyZTcxYjdMSVNoemNkbC1HU2hHa1ltLWRkbFlJUWIyOWdTODAyMVVPbm5VSXltdXNGM09oNzdOYTRURmw2NlEzcy0xdUpyeUc4VERPMmxVQXdhYXdwc2R3Z3hUN3J5U2hGcmc?oc=5","date":"2025-03-28","type":"trial","source":"AFR","summary":"The clinical trial result from hell has biotech investors on edge - AFR","headline":"The clinical trial result from hell has biotech investors on edge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVJtWGhDM1Q4WDNGNDlxUGtablVIY0NWMV9BVkN5LW5Od0dDcnZGN1k3ZmgwTTU3Wmt4Z04yaGkyM185aW1OZGdKV3BNakZMRE94QzJOYTd0enoxeXVGSC1Cam1qNXdhcUpaVHlRRVh3c0EzZVR5UjRmMU9kaC1DMW5fU2pFaTZ5VEFUcEVWNzg5bnhMYl9sbWFudkdTclpVTHNleG9IQzU5dw?oc=5","date":"2025-03-25","type":"pipeline","source":"BioSpace","summary":"Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders - BioSpace","headline":"Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE8wS3ppalZaUEpFSTZUVU95XzM0U0R1UnoyT0c3S04xcU1DMWZ2bHRqVlNSbkctZ3d3Q3ZhRmhORVFUVzUzSHl0ejYyckpybzRkaHF5aUdqYmtabW5fbHd0MTVrZzBFX0lNTVhDVjhkMy1XMDlMYmRyNFVPalVEUQ?oc=5","date":"2025-03-24","type":"trial","source":"pharmaphorum","summary":"Phase 3 readout puts Opthea at risk of insolvency - pharmaphorum","headline":"Phase 3 readout puts Opthea at risk of insolvency","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPYnJwOW1LWVZmMnQ3UW1JTW9oR3gzS0JNZHAzNmFLUDF5VkM4TW95VEhvUmtoNjNSS2RBc3ZDdk1mOXBtem1Rc2V6cnlRcElPQmhNOWFncHlfRnc0eVdkakZYeGh4Y3RSd0xabkhWQWRRT2xkdWN4eVNXdm4wa2l5WXJOUW9fWUpDU2R6U1BYYnlWM3VHQXdtWmJmRkhSVWdsZEJfTjZ4Sy1kOTRwUjg5N2Rnc1kyUWhqWWdReUVNa282MFlVRXdBSVZ2T3NPZ2s?oc=5","date":"2025-03-24","type":"trial","source":"Stockhead","summary":"Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure - Stockhead","headline":"Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNSF8xbF9kOFk3TzBRUzVFNVNFWGRLVFk1VUpiTXVfYWdUN3RyR2NMa1R3QTl1NnhjS0RpME84bHRzbmNieHhvd2JrZjlxazdZSDNHcVFTb3h2YW1jaEpSMjR6cGlSQldjSnJaVkE0NUNyY1FRRElpR1FUNU1Zenl5YVFSUUhmNTdOcmllbEVDZk5IV2xkbTBmcXlyUEh5eW5IZjZ2U2RhRVdSX0FqdzJ1NnNCN1dHYmJNRHk0NDNvNlNiZ0dfSjd5Z2VTaUpZb0dhU3V4a2JJel9RbllGY1E2b2c1d2tWdVh1elpFcW5WOUJfaF9tU3FLaDJ6c2UzUQ?oc=5","date":"2025-01-23","type":"trial","source":"PR Newswire","summary":"70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight - PR Newswire","headline":"70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZWJ0UFVWeVpsclFvVjN3SzZ4OUg3d3VqSjQzRXdWdzVUcnp3Z1pvNDlCTlBISWo1LTJEaU0zSi1CVDRTN3VjSlRJSktpRW85S3loMHJWaG5MaW1GMUdiSFJudDVzQklmQlg2V0xBOThucTRNRGFkdU1sY1dBeTZjMnptQjVhcDE3aDdfa1YtRnVieExCX2RaQnQ4bVNlZkZralpBOUtlV1lzWVZNZzZrelpNUXQ3R2h0cUE?oc=5","date":"2024-09-10","type":"trial","source":"Eyes On Eyecare","summary":"Opthea names senior leaders ahead of phase 3 wet AMD data readout - Eyes On Eyecare","headline":"Opthea names senior leaders ahead of phase 3 wet AMD data readout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPd1pRRWhhY0xjbjRVOVpRV3VXeGx2cFJCc3N4SGJLNzFEZ205SEQtc2N2Nm9zOTBNampWVzdhOW9ybm45LVE5YTN0WS1US1U5NXVpRWVlQlAxNi1JdzhRWHRmREs2RFI5NzIxNU5Kd0YzeFhTTkpJSUIzb29CZFFoQ3ZlVWV2RGRSVVRielVMd253dzNtZmpOUEdR?oc=5","date":"2024-09-10","type":"pipeline","source":"Livewire Markets","summary":"5 pharma & biotech stocks on the move in August - Livewire Markets","headline":"5 pharma & biotech stocks on the move in August","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}